12.2 Common Exam Traps & Final Checklist

Why This Matters for the Exam

The traps below aren't obscure edge cases — they're the specific distinctions PTCB's item writers return to again and again, because each one has a "sounds right but isn't" wrong answer built in. Knowing the correct fact isn't enough if you don't also recognize the exact wrong-answer pattern the exam pairs with it.

Six-Trap Quick-Reference Table

Trap 1: Required vs. Recommended CSTD Use

USP <800> draws a hard line between two verbs. CSTD use is required for administering antineoplastic HDs whenever a compatible dosage form and device exist. CSTD use is only recommended during compounding of those same drugs. Candidates who memorize "CSTDs are required" as a blanket rule miss questions that hinge on which activity — administration or compounding — is described. A second layer of this trap: some dosage forms have no CSTD-compatible pathway at all (intrathecal preparations, irrigations, ophthalmics, topical creams/ointments/gels), so a question can correctly answer "no CSTD applies here" even for a drug that would otherwise need one.

Trap 2: Single vs. Double Chemo Gloving by Task

A single ASTM D6978-tested chemo glove is acceptable for counting or handling intact final dosage forms — no cutting, crushing, or other manipulation involved. Double gloving plus a chemo gown is required for compounding, for administering antineoplastic HDs, for deactivation/decontamination cleaning tasks, and for any manipulation of an oral HD, including splitting a scored tablet. The trap runs in both directions: applying single gloving to a splitting task because "it's just a tablet," or assuming double gloving applies to every hazardous-drug interaction regardless of whether the dosage form stays intact.

Trap 3: The Four-Step Cleaning Order and Its Agents

Deactivation chemically alters the drug (when a validated agent exists); decontamination physically removes residue; cleaning removes organic and inorganic material with a germicidal detergent; disinfection reduces microorganisms and applies where a sterile environment must be protected. The order never changes. When a drug has no validated deactivating agent, personnel skip that step and proceed directly to decontamination, cleaning, and disinfection — they do not move deactivation later, and they do not skip or reorder any of the remaining three.

Trap 4: Assessment of Risk Eligibility

An Assessment of Risk can only substitute for full engineering controls on non-compounded final-dosage-form activities: counting, weighing, repackaging. The moment an activity involves compounding — even a simple nonsterile cream — AoR eligibility disappears and the full C-SCA/C-PEC requirements apply. Exam questions often describe a facility that mixes or compounds a preparation and then ask whether an AoR can substitute for engineering controls; the correct answer is no, because compounding occurred.

Trap 5: NIOSH Table 1 vs. Table 2 Classification

Table 1 drugs carry MSHI and/or NTP-known-human-carcinogen or IARC Group 1/2A classification. Table 2 drugs meet another NIOSH hazard criterion (reproductive/developmental toxicity, organ toxicity, genotoxicity, or structural similarity to a known hazardous drug) without that carcinogen classification. The trap is assuming table placement alone dictates the PPE or engineering-control decision — it identifies which drugs are hazardous, but the actual control decision still depends on dosage form, task, and manufacturer safety data.

Trap 6: Donning/Doffing Order and Contamination Containment

Donning proceeds shoe covers, then the first (inner) pair of chemo gloves, then the gown, then the second (outer) pair of gloves pulled over the gown cuffs to seal the wrist, and finally head/hair cover, mask or respirator, and eye protection — donned last, closest to the face and airway. Doffing is not a simple mirror image: outer gloves come off first (the most contaminated item), the gown is rolled inward and away from the body so its contaminated exterior never touches skin, the inner gloves come off next, and head/hair cover, mask/respirator, and eye protection are removed last, immediately followed by hand hygiene. The one rule that governs every step of doffing: a contaminated exterior surface must never touch skin.

Final Pre-Exam-Day Checklist

• What to review in your last pass: the weighted blueprint table from Section 12.1, one worked example for each of the six traps above, and any chapter where your practice-quiz accuracy sits below your personal target.
• What to bring: your Pearson VUE confirmation, a primary government-issued photo ID with signature (driver's license, passport, or state ID), and a secondary ID with signature that matches the name on your PTCB account exactly. Personal items — phones, watches, notes — are not permitted in the testing room and go into a locker.
• Timing strategy for 55 questions in 80 minutes: that's roughly 1 minute 27 seconds per question. Answer everything you're confident about on a first pass, flag anything uncertain, and don't let one difficult scenario consume the time budgeted for two or three others. Save your last several minutes to revisit flagged questions with fresh eyes rather than rushing through unseen ones at the end.

On the Exam

Expect the traps above to show up as paired options rather than as isolated true/false facts — one answer choice will state the correct rule, and at least one distractor will state the same rule with the activity, drug table, or sequence swapped (administration for compounding, Table 1 for Table 2, decontamination for deactivation). Reading the scenario once for the drug and once for the specific action being performed catches most of these before you even look at the options. Trust the preparation you've built across the last eleven chapters: the exam is testing whether you can apply six domains' worth of detail under a time limit, not whether you can recall a fact no scenario ever tests in practice.